In addition, we showed that inhibition of mutant B-Raf enhanced PMCA4b expression in BRAF mutant melanoma cells, and that PMCA4b abundance (induced either by overexpression or drug treatments) was coupled with decreased migration and metastatic activity of BRAF mutant melanoma cells [31]. The gene discussed is ATP2B4; the disease is melanoma.